Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

Have you been paying attention to shares of Weave Communications, Inc. (WEAV) ? Shares have been on the move with the stock up 7.1% over the past month. The stock hit a new 52-week high of $14.5 in the previous session. Weave Communications, Inc. has gained 23.6% since the start of the year compared to the 31.4% move for the Zacks Computer and Technology sector and the 28.6% return for the Zacks Communication - Network Software industry.What's Driving the Outperformance?The stock has a great record of posit ...

Revenue Performance - Recurring revenues accounted for 92% of total revenue for both the three and nine months ended September 30, 2024 and 2023, indicating strong revenue stability [112]. - Subscription and payment processing revenue for the three months ended September 30, 2024 was $50,375,000, up from $41,601,000 in the same period of 2023, representing a growth of 21.4% [115]. - Revenue for the three months ended September 30, 2024, was $52,386, an increase of $8,842 or 20% compared to $43,544 in the same period of 2023 [148]. - Revenue for the nine months ended September 30, 2024, increased to $150,145 thousand, up 20% from $124,776 thousand in the same period of 2023, primarily due to new customer locations [156]. Profitability and Margins - The gross profit margin for subscription and payment processing was 78% for the three months ended September 30, 2024, compared to 77% for the same period in 2023 [120]. - Cost of revenue for the same period was $14,659, up $1,050 or 8% from $13,609, while gross margin improved to 72% from 69% [149][150]. - Gross margin improved to 71% for the nine months ended September 30, 2024, compared to 68% in the same period of 2023, despite an increase in absolute cost of revenue [157]. Expenses - Sales and marketing expenses increased to $21,159, a rise of $3,358 or 19% from $17,801, primarily due to a $2.0 million increase in personnel-related expenses [151]. - Research and development expenses rose to $9,868, an increase of $1,240 or 14% from $8,628, driven by higher personnel-related costs [152]. - General and administrative expenses were $13,330, up $1,802 or 16% from $11,528, mainly due to increased personnel-related expenses and professional fees [153]. - Sales and marketing expenses rose to $62,678 thousand for the nine months ended September 30, 2024, a 19% increase from $52,474 thousand in 2023, mainly due to higher personnel-related expenses and demand generation costs [158]. - Research and development expenses increased to $29,471 thousand for the nine months ended September 30, 2024, an 18% rise from $24,907 thousand in 2023, attributed to increased headcount and salary adjustments [160]. - General and administrative expenses were $38,729 thousand for the nine months ended September 30, 2024, up 16% from $33,502 thousand in 2023, primarily due to higher personnel-related expenses [161]. Net Loss and Cash Flow - The company reported a net loss of $5,879 for the three months ended September 30, 2024, compared to a net loss of $7,145 in the same period of 2023 [145]. - The net loss for the nine months ended September 30, 2024, was $21.64 million, compared to a net loss of $23.99 million for the same period in 2023, indicating a reduction in losses [170]. - Free cash flow for the nine months ended September 30, 2024, was $4,239 thousand, compared to $3,596 thousand in the same period of 2023, reflecting improved cash generation [169]. - Cash provided by operating activities for the nine months ended September 30, 2024, was $7.48 million, an increase from $6.48 million in the same period in 2023 [176][177]. Customer Metrics - The dollar-based net retention rate improved to 98% as of September 30, 2024, up from 95% in 2023, reflecting enhanced customer retention and revenue growth [125]. - Approximately 36% of customer locations opted for annual prepayments as of September 30, 2024, down from 40% in 2023, indicating a shift in payment preferences [129]. Product Development and Innovation - The company introduced Weave Enterprise, a solution designed for organizations with multiple locations, to better serve multi-office customers [118]. - The new Weave platform features an AI-powered assistant and a modern user interface, aimed at improving practice operations and customer experience [111]. - The company is expanding its services to additional specialized medical verticals, enhancing its product offerings for dental, optometry, and veterinary practices [110]. - The company aims to continue investing in product development and marketing to enhance customer satisfaction and expand its market presence [119]. Financial Position and Liquidity - As of September 30, 2024, the company had $51.1 million in cash and cash equivalents, along with $47.1 million in other short-term investments, providing a solid liquidity position [172][173]. - The company recorded $40.2 million in deferred revenue as of September 30, 2024, which will be recognized as revenue over the subscription term [174]. - Cash used in financing activities for the nine months ended September 30, 2024, was $16.62 million, primarily due to employee taxes related to restricted stock units [181]. - The company acquired $5.2 million of additional right-of-use assets through new finance lease obligations during the nine months ended September 30, 2024 [183]. - As of September 30, 2024, the company had no outstanding balance on its $50 million credit facility, maintaining compliance with all loan covenants [188]. Future Expectations - The company expects sales and marketing expenses to continue to be the largest operating expense, but as a percentage of revenue, these expenses are anticipated to decrease in 2024 compared to 2023 [137]. - Research and development expenses are expected to increase as the business grows, but will likely remain consistent or slightly decrease as a percentage of revenue over time [139]. - The company expects operating cash flows to improve as it increases operational efficiency and experiences economies of scale [171].

Financial Data and Key Metrics Changes - Revenue for Q3 was $52.4 million, representing over 20% year-over-year growth and $1.2 million above the midpoint of the guidance range provided in July [7][34] - Gross margin reached 72.5%, an improvement from last quarter and over 300 basis points greater than Q3 of last year, marking the 11th consecutive quarter of gross margin improvement [7][38] - Non-GAAP operating income was reported at $1.4 million for the first time in the company's history, representing a $3.2 million improvement compared to last year [34][41] - Net income was $2.1 million or $0.03 per share, compared to a net loss of $1 million or $0.01 per share last year, reflecting a $3.1 million improvement due to revenue growth and operating efficiencies [41] - Free cash flow was $3.5 million in Q3, representing year-over-year growth of 70% [43] Business Line Data and Key Metrics Changes - Specialty medical was the fastest-growing category, with growth rates exceeding twice that of overall revenue growth [35] - The net revenue retention rate improved to 98% in Q3, up from 97% last quarter, indicating strong customer retention and upsell performance [36][37] - Gross revenue retention rate remained strong at 92%, consistently ranging between 91% and 94% over the past four years [37] Market Data and Key Metrics Changes - The addressable market for Weave's current focus areas (dental, optometry, veterinary, and specialty medical) exceeds $7 billion in the U.S. alone [9] - The integration of fintech solutions is expected to enhance practice growth and profitability by streamlining billing and payment processing [10] Company Strategy and Development Direction - The launch of the New Weave platform is a significant strategic milestone, enhancing market position with a robust technology infrastructure [12] - The company aims to deepen integrations with practice management systems to drive growth across target markets [29][30] - Weave is focusing on expanding its presence in the multi-location space, particularly among Dental Service Organizations (DSOs) [28] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future opportunities and the commitment to strengthening long-term value through sustained business growth [46] - The company raised its guidance for the full year 2024, expecting total revenue in the range of $202.7 million to $203.7 million [44] Other Important Information - Weave was recognized in G2's Fall 2024 Report, ranking first in multiple categories and being named a leader in patient relationship management [32] - The company has achieved a Great Place to Work certification in the U.S. for the sixth consecutive year and for the first time in India [32] Q&A Session Summary Question: When could the new Patterson relationship start to have a bigger impact on the pipeline? - Management indicated that the impact is already being seen, with higher conversion rates and growing bookings from the partnership [48] Question: What is driving the momentum in specialty medical? - The success is attributed to building integrations and addressing pent-up demand for an integrated platform [50] Question: Can you discuss the outlook for net revenue retention (NRR)? - NRR is expected to improve through increased payments and upsell products, with a focus on reducing downgrade rates [56] Question: What are the drivers for potential future margin improvement? - Future margin improvements are expected from the payments product, structural improvements from amortization, and efficient customer service [70]

NYSE: WEAV Weave Overview Q3 2024 Safe Harbor Statement This presentation has been prepared by Weave Communications, Inc. ("Weave", "we", "us", or "our") for informational purposes only and not for any other purpose. This presentation contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995 that are based on our management's current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of ope ...

Weave Announces Third Quarter 2024 Financial Results • Third quarter total revenue of $52.4 million, up 20.3% year over year • GAAP gross margin of 72.0%, up 330 basis points year over year • Non-GAAP gross margin of 72.5%, up 320 basis points year over year • GAAP Operating Loss of $6.6 million, an improvement of $1.4 million year over year • Non-GAAP Operating Income of $1.4 million, an improvement of $3.2 million year over year • Third quarter net cash provided by operating activities of $4.5 million, up ...

Financial Data and Key Metrics Changes - Revenue for Q2 was $50.6 million, representing 21.4% year-over-year growth compared to 19.2% growth last quarter, and $1.4 million above the high end of the range provided in May [4][14] - Gross margin reached 71.9%, a 400 basis point increase year-over-year, marking the 10th consecutive quarter of gross margin improvement [4][16] - Adjusted EBITDA was positive for the first time in the company's history, landing just above breakeven at $5,000, a $3 million improvement year-over-year [20] Business Line Data and Key Metrics Changes - Revenue growth was driven by new customer additions, particularly in the specialty medical vertical, and increases in average revenue per location [15] - The average revenue per customer has steadily increased over the past three years due to successful sales of higher-priced bundles [15] - The net revenue retention rate improved to 97% in Q2, up from 96% last quarter, indicating effective upselling and price adjustments [16] Market Data and Key Metrics Changes - The total addressable market in the U.S. exceeds $7 billion, with specialty medical being the fastest-growing vertical [6] - The company welcomed 20 new integrations year-to-date, opening up the addressable market by more than 86,000 locations [9] - The company continues to see strong performance in lead generation across its four core verticals, with dental being the largest source of new customers [32] Company Strategy and Development Direction - The company aims to enhance healthcare experiences through a comprehensive customer experience software and payments platform tailored to small and medium-sized healthcare practices [5] - The introduction of Weave Enterprise is designed to help multi-location practices standardize operations and streamline revenue cycle management [12] - The company is investing in AI-driven solutions to improve operational efficiency and patient engagement [8][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's execution and the stability of its customer base, which is less affected by macroeconomic trends [49] - The company raised its full-year revenue outlook to a range of $201 million to $203 million, reflecting strong performance and demand for its platform [21] - Management highlighted the importance of partnerships, particularly with Patterson Dental, to drive growth and expand market reach [40] Other Important Information - The company continues to develop innovative solutions, including AI-driven assistance and enhanced marketing tools, to improve customer experience and drive long-term loyalty [8][12] - The company has been recognized for its commitment to customer experience and workplace culture, ranking first in multiple categories by G2 and being honored on Inc.'s Annual Best Workplaces list [13] Q&A Session Summary Question: What pockets of specialty medical are seeing the most traction? - Management noted traction in physical therapy, med spa, plastics, and general practice, with a go-to-market strategy focused on brand marketing and generating inbound leads [22] Question: Is there a timeline for the rollout of the new platform? - The new Weave experience is currently being demoed, with features designed to enhance usability for multi-location practices [23][24] Question: What is the size of the installed base not on integrated bundles? - Approximately 10% of customers are on non-integrated products, with upsell opportunities available as integrations are completed [28][29] Question: What drove the strength in subscription and payment revenue? - The increase was attributed to new customer acquisition, price adjustments, and growth in payments [35][36] Question: Can you provide insights on the Patterson Dental relationship? - The partnership allows for collaborative selling into approximately 100,000 locations, with early traction and leads already being generated [40] Question: What changes have occurred in sales leadership? - Management indicated that changes have been incremental, focusing on improving the middle market business and enhancing sales strategies [42][44] Question: How is the company addressing customer retention? - The company continues to see returning customers, with many coming back after trying competitors due to the superior functionality of Weave's solutions [45] Question: What gives the company better visibility into the second half? - Strong sales performance and the stability of the customer base provide confidence in the outlook, despite macroeconomic challenges [48][49] Question: How is the Call Intelligence product performing? - Call Intelligence is still in early stages but shows promise in helping customers understand call patterns and improve revenue capture [50][51] Question: Did any other verticals reaccelerate during the quarter? - Revenue reacceleration was observed across all verticals, with specialty medical being the fastest [53]

Company Overview - Weave Communications is part of the Zacks Communication - Network Software industry, which includes Ribbon Communications (RBBN) [1] - RBBN closed the last trading session at $3.84, reflecting a 3.5% increase, and has returned 25.3% over the past month [1] Financial Performance - Weave Communications is expected to report a quarterly loss of $0.02 per share, indicating a year-over-year change of +60% [2] - Revenues for Weave are projected to be $48.84 million, representing a 17.2% increase from the same quarter last year [2] - Weave's shares increased by 7.4% in the last trading session, closing at $9.69, with notable trading volume [3] Market Trends - The stock's price movements are correlated with trends in earnings estimate revisions, which are crucial for evaluating potential stock strength [4] - The consensus EPS estimate for Weave has remained unchanged over the last 30 days, suggesting that price increases may not be sustainable without earnings estimate revisions [6] Competitive Position - Weave is benefiting from increased adoption of its solutions across various markets, including dental, optometry, veterinary, and specialty medical, which is enhancing its average revenue per user [5] - Ribbon Communications has a consensus EPS estimate of $0.04 for the upcoming report, unchanged from the previous year, and also holds a Zacks Rank of 3 (Hold) [7]

[PART I. FINANCIAL INFORMATION](index=6&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Financial Statements (Unaudited)](index=6&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) This section presents the unaudited condensed consolidated financial statements for the quarter ended March 31, 2024, including balance sheets, statements of operations, comprehensive loss, stockholders' equity, and cash flows, along with accompanying notes [Condensed Consolidated Balance Sheets](index=6&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2024, the company reported total assets of **$190.2 million**, a decrease from **$201.0 million** at year-end 2023, with total liabilities at **$116.7 million** and stockholders' equity at **$73.4 million**, alongside a significant decrease in cash and cash equivalents Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2024 | December 31, 2023 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $30,609 | $50,756 | | Total current assets | $119,722 | $129,778 | | TOTAL ASSETS | $190,174 | $201,012 | | **Liabilities & Equity** | | | | Total current liabilities | $68,360 | $72,853 | | Total liabilities | $116,738 | $122,055 | | Total stockholders' equity | $73,436 | $78,957 | | TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $190,174 | $201,012 | [Condensed Consolidated Statements of Operations](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) For the three months ended March 31, 2024, Weave generated **$47.2 million** in revenue, a **19.2% increase** year-over-year, and reported a net loss of **$7.2 million**, an improvement from the prior year Condensed Consolidated Statements of Operations Highlights (in thousands) | Account | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Revenue | $47,173 | $39,565 | | Gross profit | $32,987 | $26,534 | | Loss from operations | $(8,155) | $(8,518) | | Net loss | $(7,203) | $(7,859) | | Net loss per share - basic and diluted | $(0.10) | $(0.12) | [Condensed Consolidated Statements of Comprehensive Loss](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Loss) Total comprehensive loss for Q1 2024 was **$7.5 million**, compared to **$7.9 million** in Q1 2023, primarily driven by net loss and other comprehensive losses from foreign currency translation and unrealized investment losses Condensed Consolidated Statements of Comprehensive Loss (in thousands) | Account | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Net loss | $(7,203) | $(7,859) | | Other comprehensive loss | $(300) | $(16) | | **Total comprehensive loss** | **$(7,503)** | **$(7,875)** | [Condensed Consolidated Statements of Stockholders' Equity](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders'%20Equity) Stockholders' equity decreased from **$79.0 million** at year-end 2023 to **$73.4 million** as of March 31, 2024, primarily due to net loss and equity award settlements, partially offset by stock-based compensation - Total stockholders' equity decreased from **$78,957 thousand** at December 31, 2023, to **$73,436 thousand** at March 31, 2024[22](index=22&type=chunk) - The main drivers of the change were the net loss of **$7.2 million** and **$6.1 million** for common stock withheld for taxes, offset by **$6.8 million** in stock-based compensation[22](index=22&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=10&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operating activities was **$19.7 million** in Q1 2024, a significant negative shift from the prior year, primarily due to increased accounts receivable and decreased accrued liabilities, while investing activities provided **$6.1 million** and financing activities used **$6.6 million** Condensed Consolidated Statements of Cash Flows Highlights (in thousands) | Activity | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | $(19,701) | $1,541 | | Net cash provided by (used in) investing activities | $6,131 | $(5,439) | | Net cash used in financing activities | $(6,577) | $(2,018) | | **Net decrease in cash and cash equivalents** | **$(20,147)** | **$(5,916)** | [Notes to the Condensed Consolidated Financial Statements](index=12&type=section&id=Notes%20to%20the%20Condensed%20Consolidated%20Financial%20Statements) The notes provide detailed explanations of the company's accounting policies and financial statement components, including revenue disaggregation, the **$50.0 million** undrawn revolving line of credit, and **$6.8 million** in stock-based compensation expense for the quarter Disaggregation of Revenue (in thousands) | Revenue Category | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Subscription and payment processing | $45,092 | $37,692 | | Onboarding | $960 | $784 | | Hardware (embedded lease) | $1,121 | $1,089 | | **Total revenue** | **$47,173** | **$39,565** | - The company has a revolving line of credit with Silicon Valley Bank allowing for total borrowing capacity up to **$50.0 million**, with zero outstanding balance as of March 31, 2024[84](index=84&type=chunk)[85](index=85&type=chunk) Stock-Based Compensation Expense (in thousands) | Expense Category | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Cost of revenue | $239 | $213 | | Sales and marketing | $1,151 | $964 | | Research and development | $1,898 | $930 | | General and administrative | $3,484 | $2,406 | | **Total** | **$6,772** | **$4,513** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=28&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes the **19% year-over-year revenue growth** primarily to new customer acquisition, with gross margin improving to **70%**, while reporting a negative free cash flow of **$(20.5) million** and an improved Adjusted EBITDA loss of **$(0.4) million** - Revenue increased by **$7.6 million (19%)** year-over-year, with **87%** of the increase from new customers and **13%** from existing customers[147](index=147&type=chunk) - Gross margin improved from **67% to 70%** year-over-year, driven by reduced third-party costs, fully depreciated phone hardware for more customers, and operational efficiencies[148](index=148&type=chunk)[149](index=149&type=chunk) Key Business Metrics | Metric | March 31, 2024 | March 31, 2023 | | :--- | :--- | :--- | | Dollar-based net retention rate | 96% | 97% | | Dollar-based gross retention rate | 92% | 93% | Non-GAAP Financial Measures (in thousands) | Metric | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | | :--- | :--- | :--- | | Free cash flow | $(20,519) | $587 | | Adjusted EBITDA | $(358) | $(3,114) | - Free cash flow was negatively impacted by approximately **$15.0 million** due to a new billing system implementation deferring March billings, and by approximately **$7.0 million** due to the timing of annual bonus payouts[158](index=158&type=chunk)[159](index=159&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=42&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's exposure to market risk has not materially changed since December 31, 2023, with detailed information available in its Annual Report on Form 10-K regarding interest rate and foreign currency risks - As of March 31, 2024, the company's exposure to market risk has not changed materially since December 31, 2023[186](index=186&type=chunk) [Controls and Procedures](index=42&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of March 31, 2024, with no material changes to internal control over financial reporting identified during the quarter - Management, including the CEO and CFO, concluded that as of March 31, 2024, the company's disclosure controls and procedures were effective[187](index=187&type=chunk) - There were no changes in internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting[189](index=189&type=chunk) [PART II. OTHER INFORMATION](index=43&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Legal Proceedings](index=43&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently a party to any legal proceedings expected to have a material adverse effect on its business, financial condition, or cash flows, though future litigation, particularly intellectual property, remains a possibility - The company is not presently a party to any legal proceedings that would be expected to have a material adverse effect on its business, results of operations, financial condition, or cash flows[192](index=192&type=chunk) [Risk Factors](index=44&type=section&id=Item%201A.%20Risk%20Factors) This section details numerous risks, including the company's history of losses, dependence on SMB customers, intense market competition, reliance on third-party providers, potential security breaches, and evolving regulatory compliance challenges - The company has a history of net losses, including **$7.2 million** for Q1 2024, and may not achieve or sustain profitability in the future[211](index=211&type=chunk) - The business is highly dependent on attracting and retaining SMB customers, who are more susceptible to economic downturns and have higher failure rates[201](index=201&type=chunk)[208](index=208&type=chunk) - The company faces significant competition from a fragmented market of point solutions and larger platform providers[233](index=233&type=chunk) - There is substantial reliance on single-source or key third-party providers, including Stripe for Weave Payments and Google Cloud Platform (GCP) for cloud infrastructure, and any disruption could adversely affect business[257](index=257&type=chunk)[266](index=266&type=chunk) - The business is subject to stringent and changing regulations, including HIPAA, TCPA, and various data privacy laws (e.g., CCPA/CPRA), and non-compliance could result in significant liability and reputational harm[322](index=322&type=chunk)[334](index=334&type=chunk)[342](index=342&type=chunk) [Other Information](index=89&type=section&id=Item%205.%20Other%20Information) This section discloses that on March 6, 2024, Branden Neish, Chief Product and Technology Officer, adopted a Rule 10b5-1 trading plan for the potential sale of up to **100,000 shares** - On March 6, 2024, Branden Neish, Chief Product and Technology Officer, adopted a Rule 10b5-1 trading plan for the sale of up to **100,000 shares**[402](index=402&type=chunk) [Exhibits](index=90&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including the amended loan and security agreement, CEO/CFO certifications, and financial statements formatted in Inline XBRL - The exhibits filed with the report include the amended loan and security agreement, CEO/CFO certifications (Rule 13a-14(a) and Section 1350), and financial statements in Inline XBRL format[404](index=404&type=chunk)

Weave Announces First Quarter 2024 Financial Results LEHI, Utah—May 1, 2024 – Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced its financial results for the first quarter ended March 31, 2024. "Weave delivered another terrific quarter, providing a strong start to the year with solid top-line performance and significant improvements in gross and operating margin and adjusted EBITDA. Achieving greater ...